In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $5.49 in the prior trading day, Aura Biosciences Inc (NASDAQ: AURA) closed at $5.45, down -0.73%. In other words, the price has decreased by -$0.73 from its previous closing price. On the day, 0.13 million shares were traded. AURA stock price reached its highest trading level at $5.555 during the session, while it also had its lowest trading level at $5.3573.
Ratios:
Our goal is to gain a better understanding of AURA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.04 and its Current Ratio is at 9.04. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
On July 25, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $21.H.C. Wainwright initiated its Buy rating on July 25, 2024, with a $21 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 17 ’25 when Hopkins Janet Jill bought 17,109 shares for $5.42 per share.
Hopkins Janet Jill sold 17,109 shares of AURA for $92,731 on Nov 17 ’25. The Chief Medical Officer now owns 252,685 shares after completing the transaction at $5.42 per share. On Oct 29 ’25, another insider, Elazzouzi Amy, who serves as the Officer of the company, bought 896 shares for $6.35 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AURA now has a Market Capitalization of 346092800 and an Enterprise Value of 201980816.
Stock Price History:
The Beta on a monthly basis for AURA is 0.44, which has changed by -0.3353511 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, AURA has reached a high of $8.60, while it has fallen to a 52-week low of $4.34. The 50-Day Moving Average of the stock is -7.80%, while the 200-Day Moving Average is calculated to be -11.33%.
Shares Statistics:
The stock has traded on average 232.93K shares per day over the past 3-months and 215690 shares per day over the last 10 days, according to various share statistics. A total of 62.99M shares are outstanding, with a floating share count of 47.06M. Insiders hold about 25.89% of the company’s shares, while institutions hold 68.84% stake in the company. Shares short for AURA as of 1765756800 were 3058660 with a Short Ratio of 13.13, compared to 1763078400 on 2922667. Therefore, it implies a Short% of Shares Outstanding of 3058660 and a Short% of Float of 5.47.
Earnings Estimates
A detailed examination of Aura Biosciences Inc (AURA) is currently in progress, with 4.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.43, with high estimates of -$0.43 and low estimates of -$0.44. Analysts are recommending an EPS of between -$1.8 and -$2.52 for the fiscal current year, implying an average EPS of -$1.95. EPS for the following year is -$1.86, with 5.0 analysts recommending between -$1.7 and -$2.11.
